Laboratory studies in breast implant patients: ANA positivity, gammaglobulin levels, and other autoantibodies

Current Topics in Microbiology and Immunology

Volumn 210, Issue , 1996, Pages 337-348

  Lewy, R I ^a,c   Ezrailson, E ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b Emerald Biomedical Sciences Inc   (United States)

^c Breast Implant Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN; SILICONE;

ADULT; AUTOIMMUNITY; BLOOD LEVEL; BREAST PROSTHESIS; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETIOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SIDE EFFECT; SILICONE PROSTHESIS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; BREAST IMPLANTS; FEMALE; GAMMA-GLOBULINS; HUMANS; SILICONES;

ANIMALIA;

EID: 0030031832     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-85226-8_36     Document Type: Article

References (71)

1. Brown, JB, Fryer MP, David A (1960). Study and use of synthetic materials such as silicons and teflon as subcutaneous protheses. Plastic and Reconstruct Surg. 26:264-27.
2. Endo LP, Edwards NL, Longley S, Cormann LC, Panush RS. (1987). Silicone and rheumatic diseases. Semin Arthritis Rheum 17:112-118.
3. Fock KM, Feng PH, Tey B. (1984). Autoimmune disease developing after augmentation mammoplasty: report of 3 cases. J Rheumatol 11:98-100.
4. Goldblum RM, Pelley RP, O'Donnell AA, Pyron D, Meggers JP (1992). Antibodies to silicone elastomers and reactions to ventribuloperitoneal shunts. Lancet; 340:510-513.
5. Heggers JP, Kossovsky N, Parson RW, Robson MC, Pelley RC, Talmage RJ. (1983). Biocompatibility of silicone implants. Ann Plastic Surg 11:38-45
6. Kaiser W, Biesenback, Stuby U, Grafinger P, Zazgornik J (1990). Human adjuvant disease: remission of silicone-induced autoimmune disease after explanation of breast augmentation. Ann Rheum Dis 49:937-938.
7. Kossovsky N, Heggers JP, Robson MC (1987). Experimental demonstration of the immunogenicity of silicone-protein complexes. J Biomed Mater Res 21.1125-33.
8. Okano V, Nishikai M, Sato A. (1984). Scleroderma, primary biliary cirrhosis and Sjogren's syndrome after cosmetic breast augmentation with silicone injection a case report of possible human adjuvant disease Ann Rheum Dis 43:520-1.
9. Peimer CA, Medige J, Eckert BS, Wright JR, Howard CS (1986). Reactive synovitis after silicone arthroplasty. H Hand Surg IIA:624-38.
10. Sergott TJ, Limoli JP, Baldwin CM Jr, Laub DR. (1986). Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg 78:104-14
11. Silverstein MJ, Handel N, Gamagami P, Gierson ED, Furmanski M, Collins AR, Epstein M, Cohlan BF. (1992). Breast cancer diagnosis and prognosis in women following augmentation with silicone gel-filled prostheses Eur J Cancer 1992; 28-635-640
12. Spiera H. (1988). Scleroderma after silicone augmentation mammoplasty. JAMA 260:236-8.
13. Van Nunen SA, Gatenby PA, Basten A. (1983). Post-mammoplasty connective tissue disease. Arthritis Rheum 25:294-7.
14. Varga J, Jimenez SA. (1990). Augmentation mammoplasty and scleroderma. Is there an association? Arch Dermatol 126:1220-1221
15. Varga J, Schumacher HR, Jimenez SA. (1989). Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 111.377-83.
16. Yoshida K. (1973). Post mammoplasty disorder as an adjuvant disease of man Shikoku Acta Med 29:318-32.
17. Sontheimer RD, McCauliffe DP, et al. (1992) Antinuclear Antibodies: Clinical Correlations and Biological Significance. Adv Dermat .7:3-52
18. Lipscomb MF, Cope LD, Stephens GL, et al. (1984) Comparison of substrates for the Detection of Antinuclear Antibodies in Normals and In Patients with Connective Tissue Disease and Other Diseases. Diagn Immunol 2:181-187.
19. Anderson P. (1977). Correlation of amooth muscle and nuclear antibodies in normal subjects. Clin Exp Med 27:74-77.
20. Borak J, Vasey F, Lauter S et al. (1979). Immunofluorescence Assay for Antinuclear Factor: A Non-specific Test in Hospitalized Patients. Can Med J 121:1372-1374.
21. Shu S, Nidengard RJ, Hale WL et al (1975). Incidence and titers of Antinuclear Antismooth muscle and other autoantibodies in blood donors. J Lab Clin Med 86;259-265.
22. Carsons S. (1988). Newer laboratory parameters for the diagnosis of rheumatic disease. Am J Med 85(4A): 34-8
23. Shiel WC, Jason M. (1989) The Diagnostic Association of Patients with Antinuclear Antibodies Referred to a Community Rheumatologist. J Rheumatol. 91:249-255.
24. Smeenk RJ, van den Brink HG, Brinkman K, Termaat RM, Berden JH, Swaak AJ. (1991) Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol Int 11(3): 101-7.
25. Tan EM (1989). Antinuclear antibodies, diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 93-151.
26. De Vlam, K, De Keyser F, Verbruggen M. Et al .(1993). Detection and Identification of Antinuclear Antibodies in the Serum of Normal Blood Donors. Cliinical and Experimental Rheumatology 11:393-397.
27. Guilbert B, Dightero G, Avrameas S. (1982). Naturally Occurring Antibodies Against Nine Common Antigens in Human Sera. J Immunol 128:2279-2287.
28. Segal R, Globerson A, Singer H et al. (1992) The Influence of Aging on the Induction and Manifestations of Experimental Systemic Lupus Erythematosus. J Clin Immunol. 12:5.341-346.
29. Spiera H, Kerr LD (1993). Scleroderma following silicone implantation: a cumulative experience of 11 cases. J Rheumatol 20(6): 958-61.
30. Sahn EE, Garen PD, Silver RM, Maize JC. (1990). Scleroderma following augmentation mammoplasty. Report of a case and review of the literature [see comments] Arch Dermatol 126(9): 1198-202.
31. Gutierrez FJ, Espinoza LR. (1990). Progressive systemic sclerosis complicated by severe hypertension: reversal after silicone implant removal. Am J Med 89(3): 390-2.
32. Press RI, Peebles CL, Kumagai Y, Ochs RL, Tan EM. (1992). Antinuclear autoantibodies in women with silicone breast implants. Lancet 340(8831): 1304-7.
33. Bridges AJ. (1994) Autoantibodies in patients with silicone implants. Semin Arthritis Rheum 24(1 Sup54-60): 54-60.
34. Bridges AJ, Conley C, Wang G, Burns DE, Vasey FB. (1993). A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease [see comments] Ann Intern Med 118(12): 29-36.
35. Claman H, Robertson AD. (1994). Antinuclear Antibodies and Breast Implants. West J Med. 160:225-228.
36. Coleman, EA, Lemon SJ, Rudick J et al. (1994). Rheumatic Disease Among 1167 Women Reporting Local Implant and Systemic Problems After Breast Implant Surgery. Journal of Women's Health. 3 (3): 165-177.
37. Wolf LE, Lappe M, Peterson RD, Ezrailson EG. (1993). Human immune response to polydimethylsiloxane (silicone): screening studies in a breast Implant population. FASEB J 7(13): 1265-8.
38. Teuber SS, Rowley MJ, Yoshida SH, Ansari AA, Gershwin ME. (1993). Anticollagen autoantibodies are found in women with silicone breast implants J Autoimmun 6(3): 367-77.
39. Schusterman MA, Kroll SS, Reece GP, Miller MJ, Ainslie N, Halabi S, Balch CM. (1993). Incidence of autoimmune disease in patients after breast reconstruction with silicone get implants versus autogenous tissue: a preliminary report Ann Plast Surg 31(1): 1-6.
40. Gabriel S, O'Fallon WM, Kurland L et al. (1994). Risk of Connective Tissue Diseases and Other Disorders After Breast Implantation. Nejm 330(24):1697-1702.
41. Chang YH. (1993). Adjuvanticity and arthritogenicity of silicone. Plast Reconstr Surg 92(3): 469-73.
42. Clayton D and Hills M. (1993). Statistical Methods in Epidemiology. New York, Oxford Press. 53-62
43. Brestow NE, Day NE. (1980). Statistical Methods in Cancer Research. Vol 1-the analysis of case-control studies. IARC Scientific Publications No 32. Lyon, International Agency for Research on Cancer, 146-154
44. Kossovsky N, Zeidler M, Chun G et al. (1993). Surface Dependent Antigens Identified by High Binding Avidity of Serum Antibodies in a Subpopulation of Patients with Breast Prostheses. J of Appl. Biomat 4.281-288.
45. Garrido L, Pfeiderer B, Papisov M et al. (1993). In vivo degradation of silicones. Magn Res Med 29(6):839-843
46. Swaak AJ, Huysen V, Nossent JC, Smeenk RJ. (1990). Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus. Clin Rheumatol 9(1 Sup82-94): 82-94.
47. Winfield JB, Jarjour WN. (1991). Stress Proteins, Autoimmunity and Autoimmune Disease. Curr Top Microbiol Immunol 167:161-189
48. Weiss NL, Phillips MR, Sadock VA et al. (1990). False positive seroreactivity to Borrelia burgdorferi in rheumatic disease: the value of immunoblot analysis. Clinical Research 38:277A.
49. Yoshida SH, Teuber SS, Gerrman JB et al. (1994). Immunotoxicity of Silicone: Implications of Oxidant Balance Towards Adjuvant Activity. Fd Chem Toxic. 32: 1089-1100.
50. Yoshida SH, German JB, Fletcher MP et al. (1994). The toxic oil syndrome, a perspective on immunotoxicological mechanisms Regulatory Toxicology and Pharmacology 19:60-79.
51. Heggers JP. (1994) Immunogenic Potential of Silicones and Subsequent Clinical Implications. Problems in General Surgery. 11:(2):June, 1994.
52. Lappe MA (1993). Silicone-Reactive Disorder A New Autoimmune Disease Caused by Immunostimulation and Superantigens. 1993. Medical Hypotheses 41:348-352.
53. Drake CG, Kotzin BL. (1992). Superantigens: biology, immunology and potential role in disease J Clin Immunol 12:149-162.
54. Quinlan T, Spivack S, Mossman BT. (1994). Regulation of Antioxidant Enzymes in Lung after Oxidant Activity. Environmental Health Perspectives 102:79-87, 1994.
55. Morse J, Spiera H (1992) Autoimmune Diseases, Immunoglobutin isotypes, and lymphocyte subsets in 30 females with breast augmentation mammoplasty. J Rheum:S65: 185.
56. Barun WF. (1992). HLA molecules in autoimmune diseases. Clin Biochem 25: 187-191.
57. Fox RI, Ho-II Kang. (1992). Genetic and Environmental Factors in Systemic Sclerosis. Curr Opin in Rheum 4:875-861.
58. Pilbrant A and Strindberg B. (1975). Pharmacokinetics of 2,6-cis-Diphenythexamethylcyclotetrasiloxane in Man. Acta Pharm et Tox 36:suppl 3, 139-145.
59. Smalley DL, Puckett DH, Osborne SH et al. (1994). Immunologic Stimulation of Lymphocytes in Silicone Gel Breast Implant Patients. Abstract 7th Annual Meeting of the Association of Medical Laboratory Immunologists, Boston, Mass. July 14.
60. Ojo-Amaize E A, Conte V, Lin H et al. (1994). Silicone-Specific Blood Lymphocyte Response in Women with Silicone Breast Implants. Clin Diag. Lab Immunol:1 (6):698-695.
61. Potter M, Morrison S, Wiener F, et al. (1994). Induction of Plasmacytomas with Silicone Gel in Genetically Susceptible Strains of Mice. J Nat Canc Inst 86(14): 1058-1065.
62. Naim JO, Lanzafame RJ, van Oss CJ. (1993). Adjuvant effect of silicone-gel on antibody formation in rats. Immunol Invest 22(2): 151-61
63. Shoaib B, Patten BM and Calkins DS. (1994). Adjuvant Breast Disease. An Evaluation of 100 Symptomatic Women with Breast Implants or Silicone Fluid Injections. Keio J Med 43(2):79-87.
64. Lewy, R.I. (1994). Auto immune Markers and Imaging Abnormalities in Silicone Breast Implant Users. Clinical Research, 42(2),275A.
65. Lewy, R.I. (1994). Autoimmune Disease and Collagen Dermal Implants Annals of Internal Medicine, 120(6), 524-525.
66. Komaroff AL. (1988). Chronic fatigue syndromes: relationship to chronic viral infections. J Virol Methods 21(1-4): 3-10
67. Solomon GA. (1994). Clinical and Laboratory Profile of Symptomatic Women with Silicone Breast Implants. Sem Arth Rheum 24(1)Suppl 29-37.
68. Freundlich B, Altman C, Sandorf N et al. (1994). A Profile of Symptomatic Patients with Silicone Breast Implants: A Sjogren's-like Syndrome. Sem Arth Rheum 24(1) Suppl 44-53.
69. Borenstein D et al. (1994). Siliconosis: A Spectrum of Illness. Sem Arth Rheum 24(1) Suppl 1-7.
70. Vasey FB, Havice DL, Bocanegra TS et al. (1994). Clinical Findings in Symptomatic Women with Silicone Breast Implants. Sem Arth Rheum 24(1) Suppl 22-28.
71. Lewy RI. (1995) Antinuclear Antibodies, Lipid Disturbances and Central Nervous System Imaging Abnormalities in Silicone Breast Implant Users. Journal of Investigative Medicine 43:333A.